Article
TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.
Blood - 15 Apr 1995
Kaneko H, Misawa S, Horiike S, Nakai H, Kashima K
Abstract excerpt
We examined TP53 mutation in 57 patients with myelodysplastic syndrome (MDS) at either the MDS phase or at the terminal leukemic phase using polymerase chain reaction-mediated single-strand conformation polymorphism (PCR-SSCP) analysis. TP53 mutations within exons 5 through 8 were found in seven patients. All these mutations were detected at the presentation of MDS whether these patients showed leukemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
